. Recently, Sundblad et al. [5] identified ENO1 as an antigen of antiovarian antibodies. Antibodies directed against ENO1 were found in 19.1% of sera obtained from 110 patients with POF [5] . It has been also reported that glycolysis is a major contributor to energy production in ovarian follicles [6] [7] [8] and glycolysis in ovarian follicles is required for follicle growth and estradiol secretion [9] .
ENO1 mRNA is detected in granulosa cells and theca cells of preantral and antral follicles in the rat ovary [10] . ENO1 protein is also detected in the human ovary [5, 11] . On the other hand, ENO2 mRNA is known to be expressed in ovaries of neonatal rats [12] . The levels of ovarian ENO2 mRNA increases at the primordial to primary follicle transition [12] . However, the expression of ENO2 and the cellular localization of ENO2 are unknown in the adult ovary.
In the present study, we examined the expression and cellular localization of ENO2 in the ovary and compared with those of ENO1. We found that the levels of ovarian ENO2 mRNA, but not ENO1, changed significantly during the estrus cycle. It is known that exposure to human CG (hCG) stimulates glycolytic activity in ovarian follicles [8, 9] . These suggest that gonad-formed on each gene with ovarian RNA without reverse transcription. The PCR products and 100-bp DNA ladder were electrophoresed in 2% agarose gels containing ethidium bromide and detected by UV irradiation. Intensities of PCR products were quantified using Image J 1.40f program (NIH, http//rsb.Info.nih.gov/ij/). The products were subcloned into pT7 blue-T vector (Novagen, Madison, WI, USA) for sequencing analysis. Data are expressed as mean ± SEM. Differences between the groups were analyzed by a nonparametric analysis of variance (Kruskal-Wallis-H test) followed by Dunn's post-hoc comparison.
In situ hybridization
Ovarian sections were soaked in 0.2M triethanolamine with gradually added acetic anhydride (final 0.5%) for acetylation. Then the sections were prehybridized with 50% formaldehyde in SSC (150 mM sodium chloride and 15 mM sodium citrate, pH 7.0) at 45C for 30 min. PCR product generated by RT-PCR was used as a template DNA for further amplification of the region containing site-directed promoter sequences in 5'-and 3'-termini. The primer sequences are shown in Table 2 . Fluorescein-labeled cRNA probes were obtained using a DIG Northern Starter Kit and Fluorescein RNA Labeling Mix (Roche, Mannheim, Germany). Sections were hybridized overnight at 45C with RNA probes dissolved in hybridization solution [1× Denhardt's solution, 10% dextran sulfate, 50% formaldehyde, 10 mM Tris-HCl (pH 7.6), 600 mM NaCl, 1 mM EDTA, 0.25% SDS, and 200 μg/mL herring sperm DNA]. After washing, the sections were mounted with ProLong Gold antifade reagent with 4´,6-diamidino-2-phenylindole (Invitrogen, Carlsbad, CA, USA), and viewed using a Zeiss LSM510 confocal microscope. The developmental stages of ovarian follicles were determined as described previously [14] .
Western blotting
Ovaries and brains were homogenized in ice-cold PBS and then centrifuged. Proteins in the supernatant were precipitated by adding trichloroacetic acid (final 10%). Proteins (20 μg) were resolved by SDS-PAGE (12.5% polyacrylamide) and blotted onto a polyvinylidene difluoride membrane using a semi-dry condition. The membrane was incubated overnight at room temperature with a rabbit polyclonal antibody raised against ENO2 (Millipore, Billerica, MA, USA) at dilution of 1:1000 with PBS. The immunoreactive prootropins may affect ovarian ENO2 expression. Thus, the effects of gonadotropins on ovarian ENO2 expression were examined.
Materials and Methods

Chemicals
All chemicals used in experiments were purchased from Sigma (St Louis, MO, USA) or Wako Pure Chemical Industries (Tokyo, Japan), unless otherwise noted.
Animals
Adult (10 to 12 week old) and immature (3 week old) female Wistar-Imamichi rats were used. The stages of the estrous cycle in adult rats were determined by vaginal cytology. Ovaries and brains were excised immediately after decapitation of the animals (n = 5 per each stage of estrous cycle). In an experiment, oocytes, granulosa cells, and theca and interstitial cells were mechanically separated from ovaries of a 12-week old female rat. Granulosa cells were further purified by density-gradient centrifugation with FicollPaque PLUS (GE Healthcare Japan, Tokyo, Japan). The brain was used as a positive control. ENO2 is known to be expressed in the neurons [13] . To investigate the effects of gonadotropins on ovarian expression of ENOs, immature rats were subcutaneously injected with saline, 10 IU eCG or 10 IU hCG (n = 5 per group). At 6h after the injection, tissues were dissected and either processed by histological protocols or stored at -80C. For histological analyses, tissues were fixed overnight in phosphate-buffered saline pH 7.4 (PBS) containing 4% paraformaldehyde, dehydrated, embedded in paraffin, and 6-μm serial sections were prepared. All experimental protocols were approved by the St. Marianna University School of Medicine Animal Care and Use Committee.
RT-PCRs
Total RNAs (1 µg) isolated from tissues of each rat were reverse transcribed, and partial sequences for ENO1, 2 and 3 were amplified using an RNA PCR kit (TaKaRa, Shiga, Japan). To check the integrity of the RNA from each sample, PCR using a primer set for β-actin was also performed. The sequences of primer sets and annealing temperatures for each gene were shown in Table 1 . PCR conditions were as follows: each 30 sec of denaturation at 94C, annealing and extension at 72C were repeated 30 times. Control PCRs were per-expressed in the ovary. Brain was used as a positive control. Western blot analysis using anti-ENO2 antibody showed that a single immunopositive band with a molecular mass of 47 kD was detected in both ovary and brain obtained from adult female rat (Fig. 1K) . Immnohistochemical analyses using the same antibody revealed that ENO2 protein was detected primarily in theca cells of preantral and antral follicles (Fig. 1M-O) as well as neurons (Fig. 1P ). In addition, ENO2 protein was detected in oocytes of primary, preantral and antral follicles (Fig. 1L-O) . Weak positive signals for ENO2 protein were detected in granulosa cells of preantral and antral follicles (Fig. 1M-O) .
The ovarian levels of ENO2 mRNA but not ENO1 mRNA change in the estrous cycle.
We examined the expression of ENO1 and ENO2 in adult rat ovaries at 4 stages of the estrous cycle by RT-PCR analyses. Although no significant difference was detected in ovarian ENO1 mRNA levels among the stages of the estrous cycle (Fig. 2B) , ENO2 mRNA levels significantly changed during the estrous cycle (Fig.  2C) . Its levels at metestrus were significantly lower than those at estrus.
Gonadotropin injection increases ovarian ENO2 expression.
The effects of gonadotropins on ovarian ENO1 and ENO2 expression were examined. The injection teins were chemiluminescently detected using a horseradish peroxidase-conjugated antibody against rabbit IgG (Millipore) and Supersignal West Dura (Pierce Biotechnology, Rockford, IL, USA) as a substrate.
Immunohistochemistry
Tissue sections were incubated overnight at room temperature with anti-ENO2 antibody at 1:250 dilution. Immunoreactivities were detected by development of 3,3'-diaminobenzidine using a Histofine Simple stain rat MAX-PO kit (Nichirei, Tokyo, Japan), followed by counterstaining with Mayer's hematoxylin. No staining was apparent when the primary antibodies were omitted.
Results
The rat ovary expresses not only ENO1 but also ENO2.
ENO1 and ENO2 mRNAs were detected in oocytes, granulosa cells, and theca and interstitial cells obtained from adult rat ovaries by RT-PCR analyses, however, ENO3 mRNA was undetectable (Fig. 1A) . ENO1 mRNA was mainly detected in cumulus and mural granulosa cells of antral follicle (Fig. 1B and C) . In addition, weak positive signals for ENO1 mRNA were detected in oocytes and theca cells. ENO2 mRNA was detected in oocytes, granulosa and theca cells of antral follicle (Fig. 1E and F) .
Next, we examined whether ENO2 protein was injections of hCG or eCG to immature rats up-regulated ovarian expression of ENO2: hCG increased ENO2 expression in oocytes and theca cells of preantral and antral follicles, and eCG did in theca cells of these follicles. In contrast, hCG and eCG did not affect the expression of ENO1, which was mainly expressed in granulosa cells. hCG and eCG are known to mimic the effects of LH and FSH, respectively. Therefore, we suggest that endogenous gonadotropins, LH, FSH and CG, up-regulate expression of ENO2 in oocytes and theca cells of preantral and antral follicles, which would activate glycolysis in these cells. Glycolysis is a major contributor to energy production in ovarian follicles [6] [7] [8] . Thus, gonadotropin-stimulation of the glycolysis in oocytes and theca cells would activate ovarian functions such as follicle growth and maturation, and hormone production. It has been known that expoof hCG, which mimics the effect of LH, into immature rats increased significantly ENO2 mRNA levels in the ovaries (Fig. 3A and B) . Similarly, eCG, which shows FSH-like effects, increased ENO2 mRNA levels. However, hCG and eCG did not affect ovarian ENO1 mRNA levels. Immunohistochemistry revealed that hCG mainly increased the expression of ENO2 in oocytes and theca cells of preantral and antral follicles (Fig. 3C) , while eCG did in theca cells of these follicles (Fig. 3D) .
Discussion
In the present study, we found that adult rat ovary expressed not only ENO1 but also ENO2. The ovarian levels of ENO2 mRNA, but not ENO1 mRNA, changed significantly in the estrous cycle. Furthermore, single ENO1 and ENO2 mRNAs increase at the primordial to primary follicle transition.
In the present study, we found that ovarian ENO2 mRNA levels decreased at metestrus and that hCG and eCG up-regulated ovarian expression of ENO2. In addition, serum gonadotropin levels are low at metestrus [15, sure to hCG stimulates glycolytic activity in ovarian follicles [8, 9] and that glycolysis in ovarian follicles is required for follicle growth and estradiol secretion [9] . In addition, the expression of ENOs varies according to the pathophysiological, metabolic or developmental conditions of cells [1, 12] , e.g., the levels of ovarian ral and antral follicles [12, [23] [24] [25] , demonstrating that oocytes metabolize glucose via glycolysis. It has been suggested that reduced glycolytic activity in the mature oocyte are indicative of reduced developmental potential in the resulting embryo [26] . Thus, it is suggested that LH and CG stimulates glycolysis in oocytes, which leads to the activation of meiosis. Alternatively, it has been reported that glycolytic activity is low [10, 27] and that glycolysis may not be a major contributor to energy production in immature oocytes [25, 27, 28] LH/CG and FSH receptors are known to be expressed in theca cells [17] . Thus, the present study suggests that hCG and eCG directly acts on theca cells to up-regulate ENO2 expression. However, it is unknown whether hCG or LH directly acts on oocytes, although oocytes may express LH/CG receptors [18, 19] . Alternatively, hCG or LH may up-regulate ENO2 expression in oocytes via signaling from surrounding somatic cells: LH increases the expression of epidermal growth factor (EGF) family proteins amphiregulin (AREG) and epiregulin (EREG) in granulosa cells [20] , and then AREG and EREG bind EGF receptor in oocytes, which activate oocyte functions [21, 22] . In this study, we also found that hCG and eCG displayed different effect, i.e., hCG increased ENO2 expression in oocytes and theca cells of preantral and antral follicles, and eCG did in theca cells of these follicles. The up-regulation of ENO2 expression in oocytes by hCG may occur by the mechanism involving AREG and EREG.
Glycolytic activity and glycolytic enzymes are detected in mammalian oocytes of primary, preant-
